The role of influenza in the severity and transmission of respiratory bacterial disease.

[1]  P. K. Olitsky,et al.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS , 1922, The Journal of experimental medicine.

[2]  R. Shope.  SWINE INFLUENZA III. FILTRATION EXPERIMENTS AND ETIOLOGY , 1931 .

[3]  Brightman Ij.  Streptococcus Infection Occurring in Ferrets Inoculated with Human Influenza Virus. , 1935 .

[4]  I. J. Brightman.  Streptococcus Infection Occurring in Ferrets Inoculated with Human Influenza Virus * , 1935, The Yale journal of biology and medicine.

[5]  O. Woolpert,et al.  REACTIONS OF MONKEYS TO EXPERIMENTAL MIXED INFLUENZA AND STREPTOCOCCUS INFECTIONS , 1947, The Journal of experimental medicine.

[6]  C. G. Harford,et al.  EFFECT OF THE LESION DUE TO INFLUENZA VIRUS ON THE RESISTANCE OF MICE TO INHALED PNEUMOCOCCI , 1949, The Journal of experimental medicine.

[7]  T N FISHER,et al.  The reaction of influenza viruses with guinea pig polymorphonuclear leucocytes. II. The reduction of white blood cell glycolysis by influenza viruses and receptor-destroying enzyme (RDE). , 1956, Virology.

[8]  N. Masurel,et al.  Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. , 1958, Lancet.

[9]  J. Hers,et al.  Broad aspects of the pathology and pathogenesis of human influenza. , 1961, The American review of respiratory disease.

[10]  E. D. Kilbourne,et al.  THE INFLUENCE OF INFLUENZA VIRUS INFECTION ON EXOGENOUS STAPHYLOCOCCAL AND ENDOGENOUS MURINE BACTERIAL INFECTION OF THE BRONCHOPULMONARY TISSUES OF MICE , 1961, The Journal of experimental medicine.

[11]  G. Burch,et al.  Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. , 1961, Archives of internal medicine.

[12]  R. Parker.  The Pathology of Uncomplicated Influenza , 1963, Postgraduate medical journal.

[13]  M. Seller.  SCREENING FOR NEURAL-TUBE DEFECTS , 1975, The Lancet.

[14]  M. Plotkowski,et al.  Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. , 1986, The American review of respiratory disease.

[15]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[16]  T. van der Poll,et al.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.

[17]  Y. Kurono,et al.  Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  J. Stark,et al.  Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. , 2001, Journal of virological methods.

[19]  J. Rehg,et al.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.

[20]  I. Shalit,et al.  Immunomodulatory effects of quinolones. , 2003, The Lancet. Infectious diseases.

[21]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[22]  J. McCullers,et al.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[23]  T. van der Poll,et al.  IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.

[24]  R. de Groot,et al.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease. , 2004, The Lancet. Infectious diseases.

[25]  Y. Hirakata,et al.  Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice , 2004, European Respiratory Journal.

[26]  J. McCullers.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. , 2004, The Journal of infectious diseases.

[27]  Shabir A Madhi,et al.  A role for Streptococcus pneumoniae in virus-associated pneumonia , 2004, Nature Medicine.

[28]  J. McCullers,et al.  Respiratory viruses predisposing to bacterial infections: role of neuraminidase , 2004, The Pediatric infectious disease journal.

[29]  T. van der Poll,et al.  Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. , 2004, The Journal of infectious diseases.

[30]  J. McCullers,et al.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia. , 2005, The Journal of infectious diseases.

[31]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[32]  R. Zinkernagel,et al.  Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses , 2006, Proceedings of the National Academy of Sciences.

[33]  R. Webby,et al.  Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent Manner , 2006, Journal of Virology.

[34]  A. Harmsen,et al.  Both Influenza-Induced Neutrophil Dysfunction and Neutrophil-Independent Mechanisms Contribute to Increased Susceptibility to a Secondary Streptococcus pneumoniae Infection , 2006, Infection and Immunity.

[35]  T. van der Poll,et al.  Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[36]  J. Rehg,et al.  Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets , 2006, Infection and Immunity.

[37]  T. van der Poll,et al.  Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. , 2006, The Journal of infectious diseases.

[38]  A. Harmsen,et al.  Effects of influenza infection on neutrophil function and increased susceptibility to a secondary Streptococcus pneumoniae infection , 2006 .

[39]  J. McCullers,et al.  Novel Strategy to Prevent Otitis Media Caused by Colonizing Streptococcus pneumoniae , 2007, PLoS Pathogens.

[40]  J. Rehg,et al.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.

[41]  Kelli L Boyd,et al.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.

[42]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  D. Metzger,et al.  Interleukin-12 Promotes Gamma Interferon-Dependent Neutrophil Recruitment in the Lung and Improves Protection against Respiratory Streptococcus pneumoniae Infection , 2007, Infection and Immunity.

[44]  A. Didierlaurent,et al.  The impact of successive infections on the lung microenvironment , 2007, Immunology.

[45]  B. Lambrecht,et al.  Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection , 2008, The Journal of experimental medicine.

[46]  D. Metzger,et al.  Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection , 2008, Nature Medicine.

[47]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[48]  B. Lei,et al.  Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection. , 2009, The Journal of infectious diseases.

[49]  D. Morens,et al.  Bacterial pathogens and death during the 1918 influenza pandemic. , 2009, The New England journal of medicine.

[50]  J. Weiser.  The pneumococcus: why a commensal misbehaves , 2010, Journal of Molecular Medicine.

[51]  J. McCullers,et al.  Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. , 2009, The Journal of infectious diseases.

[52]  H. Kinney,et al.  Bacterial Pathogens and Death during the 1918 Influenza Pandemic , 2009 .

[53]  A. Shahangian,et al.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. , 2009, The Journal of clinical investigation.

[54]  Thomas B. Clarke,et al.  Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. , 2009, The Journal of clinical investigation.

[55]  K. Yanagihara,et al.  Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection. , 2009, Japanese journal of infectious diseases.

[56]  M. Eisenhut.  Influenza virus amplifies interaction of polymeric immunoglobulin receptor with pneumococcal surface protein A, which mediates invasion by pneumococcus. , 2010, The Journal of infectious diseases.

[57]  L. Brown,et al.  Influenza A virus facilitates Streptococcus pneumoniae transmission and disease , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  L. Hall-Stoodley,et al.  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. , 2010, American journal of respiratory cell and molecular biology.

[59]  Kelli L Boyd,et al.  Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. , 2010, The Journal of infectious diseases.

[60]  R. Leggiadro.  Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1) – United States, May–August 2009 , 2010 .

[61]  E. Sanders,et al.  Otitis media and its consequences: beyond the earache. , 2010, The Lancet. Infectious diseases.

[62]  R. Medzhitov,et al.  Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. , 2010, Cell host & microbe.

[63]  J. Alcorn,et al.  Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice , 2011, The Journal of Immunology.

[64]  Kimberly M. Davis,et al.  Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. , 2011, The Journal of clinical investigation.

[65]  K. Yanagihara,et al.  Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection. , 2011, Japanese journal of infectious diseases.

[66]  K. Ariyoshi,et al.  Association Between Nasopharyngeal Load of Streptococcus pneumoniae, Viral Coinfection, and Radiologically Confirmed Pneumonia in Vietnamese Children , 2011, The Pediatric infectious disease journal.

[67]  N. Van Rooijen,et al.  Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis , 2011, The American Journal of Pathology.

[68]  J. McCullers,et al.  Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. , 2011, The Journal of infectious diseases.

[69]  Daniel S. Chertow,et al.  Lethal Synergism of 2009 Pandemic H1N1 Influenza Virus and Streptococcus pneumoniae Coinfection Is Associated with Loss of Murine Lung Repair Responses , 2011, mBio.

[70]  A. Wise,et al.  Influenza virus induces bacterial and nonbacterial otitis media. , 2011, The Journal of infectious diseases.

[71]  Susan M. Huse,et al.  Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis , 2011, PloS one.

[72]  B. Levin,et al.  The Anticipated Severity of a “1918-Like” Influenza Pandemic in Contemporary Populations: The Contribution of Antibacterial Interventions , 2012, PloS one.

[73]  P. Reading,et al.  Increased Nasopharyngeal Bacterial Titers and Local Inflammation Facilitate Transmission of Streptococcus pneumoniae , 2012, mBio.

[74]  R. Webby,et al.  Naturally Occurring Swine Influenza A Virus PB1-F2 Phenotypes That Contribute to Superinfection with Gram-Positive Respiratory Pathogens , 2012, Journal of Virology.

[75]  M. Frieman,et al.  Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. , 2012, Immunology letters.

[76]  K. R. Short,et al.  Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? , 2012, Future microbiology.

[77]  M. Eisenhut.  Inhibition of epithelial sodium channels and reduction of ciliary function in influenza. , 2012, American journal of respiratory cell and molecular biology.

[78]  T. Moran,et al.  Type I Interferon Induction during Influenza Virus Infection Increases Susceptibility to Secondary Streptococcus pneumoniae Infection by Negative Regulation of γδ T Cells , 2012, Journal of Virology.

[79]  M. Haber,et al.  Invasive Pneumococcal Pneumonia and Respiratory Virus Co-infections , 2012, Emerging infectious diseases.

[80]  P. Thomas,et al.  Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections , 2013, The Journal of Immunology.

[81]  A. Hakansson,et al.  Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease , 2013, mBio.

[82]  G. Papanicolaou,et al.  Effect of Linezolid on Clinical Severity and Pulmonary Cytokines in a Murine Model of Influenza A and Staphylococcus aureus Coinfection , 2013, PloS one.

[83]  Ruslan Medzhitov,et al.  Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection , 2013, Science.

[84]  P. Reading,et al.  Antibodies Mediate Formation of Neutrophil Extracellular Traps in the Middle Ear and Facilitate Secondary Pneumococcal Otitis Media , 2013, Infection and Immunity.

[85]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[86]  J. McCullers,et al.  Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice. , 2013, The Journal of infectious diseases.

[87]  G. B. Karlsson Hedestam,et al.  Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae , 2013, Cellular microbiology.

[88]  T. van der Poll,et al.  Limited Anti-Inflammatory Role for Interleukin-1 Receptor Like 1 (ST2) in the Host Response to Murine Postinfluenza Pneumococcal Pneumonia , 2013, PloS one.

[89]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[90]  C. Steiner,et al.  Identifying the Interaction Between Influenza and Pneumococcal Pneumonia Using Incidence Data , 2013, Science Translational Medicine.

[91]  Aldert L. Zomer,et al.  Influenza-Induced Inflammation Drives Pneumococcal Otitis Media , 2013, Infection and Immunity.

[92]  K. Fukudome,et al.  Toll-Like Receptor 4 Agonistic Antibody Promotes Innate Immunity against Severe Pneumonia Induced by Coinfection with Influenza Virus and Streptococcus pneumoniae , 2013, Clinical and Vaccine Immunology.

[93]  G. Viegi,et al.  Risk factors for community-acquired pneumonia in adults in Europe: a literature review , 2013, Thorax.

[94]  E. Sanders,et al.  Viral and Bacterial Interactions in the Upper Respiratory Tract , 2013, PLoS pathogens.

[95]  M. Mina,et al.  Pathogen Replication, Host Inflammation, and Disease in the Upper Respiratory Tract , 2013, Infection and Immunity.

[96]  O. Garin,et al.  Benefit of Conjugate Pneumococcal Vaccination in Preventing Influenza Hospitalization in Children: A Case-control Study , 2013, The Pediatric infectious disease journal.

[97]  M. Mina,et al.  Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[98]  Michael Worobey,et al.  Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus , 2014, Proceedings of the National Academy of Sciences.

[99]  K. Edwards,et al.  The Role of Influenza and Parainfluenza Infections in Nasopharyngeal Pneumococcal Acquisition Among Young Children , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[100]  V. Boggaram,et al.  Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production. , 2014, The Journal of infectious diseases.

[101]  J. McCullers,et al.  Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice. , 2014, The Journal of infectious diseases.

[102]  J. McCullers,et al.  Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice , 2014, mBio.